Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue October 2015
 •  Sealed Air Joining Amazon Dash  •  Put Your Face On A Candle!  •  Fusion Brands America Names New President  •  Andy Kaufman To Return...  •  Camille Rose Expands In Mass Market

Antimicrobial Agents

Published September 11, 2008
Related Searches: active award patent anti
Post a comment
U.S. Patent No. 7,407,940
Helix BioMedix, Inc., a Bothell, WA maker of boactive peptides, has been awarded a patent that covers a family of hexapeptide antimicrobial agents, including HB1345, for use as broad spectrum topical anti-infectives. HB1345 will be developed initially for dermatological indications such acne, rosacea and atopic dermatitis. Subsequent clinical applications are anticipated to include prevention of hospital acquired infections, such as those caused by MRSA and other multi-resistant pathogens.

blog comments powered by Disqus